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Highlights 
The formation of P. aeruginosa inhibition zone during Tobramycin agar diffusion 
susceptibility tests is due to a switch from planktonic growing bacteria to the biofilm 
mode of growth. 
Small aggregates in the inhibition zone (young biofilms) containing ≤≈64 P. 
aeruginosa cells are killed by tobramycin. Larger aggregates survive and form the 
inhibition zone. 
P. aeruginosa at the border of the stable inhibition zone and beyond continues to 
grow to a mature biofilm and produces large amount of polysaccharide containing 
matrix. 
The inhibition zone gives the clinical important information, that biofilm growing 
bacteria are tolerant to the antibiotic and the clinician will probably not be successful 
to treat and eradicate biofilm infections with the conventional doses of tobramycin. 
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Abstract 
Pseudomonas aeruginosa PAO1 (MIC 0.064µg/ml) was used to perform agar 
diffusion tests employing tobramycin containing tablets. The growth of the bacteria 
and the formation of inhibition zones were studied by stereomicroscopy and by 
blotting with microscope slides and staining with Methylene blue, Alcian blue and a 
fluorescent lectin for the P. aeruginosa PSL which was studied by confocal laser 
scanning microscopy. The diffusion of tobramycin from the deposit was modelled by 
using a 3D geometric version of Fick’s 2nd law of diffusion. The time-dependent 
gradual increase of Minimal Biofilm Eradication Concentration (MBEC) was studied 
by the Calgary Biofilm Devise. The early inhibition zone was visible after 5 h 
incubation. The corresponding calculated tobramycin concentration at the border was 
1.9µg/ml and increased to 3.2µg/ml and 6.3µg/ml after 7 and 24 h incubation. The 
inhibition zone increased to the stable, final zone after 7 h incubation. Bacterial 
growth and small aggregate formation (young biofilms) took place inside the 
inhibition zone until the small aggregates contained ≤≈64 cells and production of 
polysaccharide matrix including PSL had begun, thereafter the small bacterial 
aggregates were killed by tobramycin. The bacteria at the border of the stable 
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inhibition zone and beyond continued to grow to a mature biofilm and produced large 
amount of polysaccharide containing matrix. The formation of the inhibition zone 
during the agar diffusion antibiotic susceptibility test is due to a switch from the 
planktonic to the biofilm mode of growth and gives clinical important information 
about the increased antibiotic tolerance of biofilms.  
 
 
 
Introduction 
Soon after antibiotics began to be used to treat infections, the need for testing the 
susceptibility of the offending bacteria to various antibiotics became urgent, since 
occurrence of resistant mutants of otherwise susceptible species became a problem. 
The agar diffusion method became the most popular and clinical used method 
employing agar cups, disks or tablets as deposits (1-6). The method was repeatedly 
standardized internationally (7), and by CLSI in USA (www.clsi.org) and EUCAST in 
Europe (www.eucast.org) and is regarded as a good method for categorizing bacteria 
as susceptible (S), intermediate susceptible (I) and resistant (R) to systemic use of 
antibiotics in accordance with the harmonised breakpoints (8)  (www.eucast.org, 
www.clsi.org). The diffusion of antibiotics from the deposit in a disk or tablet takes 
place in water within a 1% agar plate and follows Fick’s 2nd law of diffusion. The 
size of the inhibition zone was shown to be dependent not only on the minimal 
inhibitory concentration (MIC) but also on the lag phase, the generation time of the 
bacterial strain and its inoculum, the amount of antibiotic in the tablet, and the 
diffusibility of the antibiotic, (www.eucast.org). The formation of the inhibition zone 
is readable after ≤5 hours incubation but increases marginally during the next hours 
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after which it becomes stable and the colonies at the border and beyond the inhibition 
zone continues to grow overnight.   
These characteristics of the formation of the inhibition zone indicate, that it may be 
the transition from a planktonic mode of growth (the inoculum) to a biofilm mode of 
growth which is decisive for the formation of the inhibition zone. The present study, 
therefore, aims to investigate the influence of the transition from planktonic to biofilm 
mode on the formation of the inhibition zone of P. aeruginosa around a tablet 
containing tobramycin. The Pharmacokinetic/Pharmacodynamic characteristics of 
tobramycin is concentration dependent killing (9). 
 
 
Materials and methods 
Bacterial strain. Pseudomonas aeruginosa PAO1 (10) was used for the experiments. 
The planktonic minimal inhibitory concentration (MIC) of tobramycin measured by e-
test is 0.064µg/ml for PAO1. Inocula of 10
7 
Colony Forming Units (CFU)/ml (7) or 
10
8 
CFU/ml (EUCAST = MacFarlane 0.5 (www.eucast.org)) were used and the plates 
were inoculated by floating. The low inoculum gives a 2mm bigger zone diameter of 
inhibition and 1.5h longer time to study the growth of microcolonies before the 
inhibition zone is formed and vice versa concerning the high inoculum. 
Antibiotic tablets and antibiotic susceptibility agar medium. NEOSENSITABS (9 mm 
diameter) with 40µg diffusible tobramycin/tablet (MW 467.54, formula 
C18H37N5O9) (ROSCO A/S, Tåstrup, Denmark).  At temperature        
  the 
diffusion constant for tobramycin is around                             
(11).  
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Cation-adjusted horse blood agar susceptibility medium (SSI Diagnostica, State 
Seruminstitute, Hillerød, Denmark) was employed.  For some experiments, where 
visualisation of the bacterial growth was required on transparent agar, LB agar plates 
were employed (SSI Diagnostica, State Seruminstitute, Hillerød, Denmark). 
Inoculation, incubation and reading of the plates and stereomicroscopy of the plates 
was done by two of the authors (NH, URJ) in the incubation cabinet at 37
o
C 
employing an Olympus SZ61 stereomicroscope (Olympus, Tokyo, Japan). 
Microscopy examination of stained slides was done with an Olympus BX50 light 
microscope (Olympus, Tokyo, Japan). Confocal laser scanning microscopy was done 
with a Zeiss LSM510 confocal laser scanning microscope (Carl Zeiss, Jena, 
Germany).  
The gradual increase of Minimal Biofilm Eradication Concentration (MBEC) of 
tobramycin by increasing age (h) of the biofilm was determined in microtiter plates 
with the Calgary Biofilm Device method (Fig. 1 & supplemental to Fig 1), using an 
inoculum of 10
7
 CFU/ml (12) (NUNC, Roskilde, Denmark), as reported previously 
(13). 
Stains: Methylene blue (Sigma-Aldrich Denmark, Copenhagen, Denmark), Alcian 
blue (Sigma-Aldrich Denmark, Copenhagen, Denmark), PSL-specific FITC-HHA 
lectin (EY Laboratories, San Mateo, CA, USA) (14). 
 
Calculation of the concentration of tobramycin in the agar plate. 
The diffusion of antibiotics in the agar plate follows Fick’s 2nd law of diffusion 
equation: 
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where   is the diffusion constant for the antibiotic. This is valid when there is no 
significant consumption of antibiotics and when the agar concentration is just a few 
percent (15). We assume that there is no significant adsorption of tobramycin to agar.  
Cylindrical geometry: 
In the idealised situation where the antibiotics is added in a small cylindrical hole in 
the middle of the agar plate, this produces the Gaussian shaped solution  
 (   )  
 
    
   (       ) 
Here we have normalized such that it integrates to one when integrated in the plane. If, 
instead, we wish to express the concentration as mass/volume we get  
 (   )  
 
  
 
    
   (       ) 
Here  is the mass of antibiotics added at the centre and    is the height of the agar.  
In practice, we do not start with a concentration in a narrow cylinder at the centre. 
Rather, the antibiotics is added in a cylinder with finite radius   . The antibiotics is 
therefore already spread with the variance in a cylinder,    
 
 
  
 . The radial 
variance of the Gaussian distribution is       . The time required to build up this 
variance is therefore  
   
  
 
  
 
Including this advance spread we get the approximate solution 
 (   )  
 
  
 
   (    )
   (    (  (    ))) 
In supplemental to Fig. 2, we show a comparison between the full calculation for 
selected radii and the shifted Gaussian version. The specific calculation concerning 
the tobramycin containing NEOSENSITABS® (ROSCO a/s, Taastrup, Denmark) is 
performed with cylinder radius         , agar height       , and tobramycin 
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mass      . The radius of the small agar plate is        and the reflective 
boundary does not influence the results in Fig. 2 and supplemental to Fig. 2. For some 
experiments larger agar plates were used with a radius of 70mm.  
Full 3D geometry: 
If the deposition of antibiotics is as a tablet on top of the agar, we need to carry out a 
full 3-dimensional calculation. The NEO-SENSITABS
®
 tablets are of radius     
      and height          . Therefore, the thickness of the tablet cannot be 
assumed to be much smaller than the height of the agar. The v/v concentration of the 
water in the tobramycin tablets may be estimated by weighing the tablets before and 
after they are placed on the agar surface and filled with water by capillary forces. The 
weight of the tablets increases by 43µg leading to a porosity (volume fraction 
occupied by water) of        . The tortuosity of the porous channels will be taken 
as          from the Bruggeman model (16). If we assume that the porosity does 
not vary in time the modified diffusion equation reads  
   
  
  
   (  
 
 
    ) 
where  (     ) is the concentration of antibiotics in the water segment. 
The diffusion equation is required to be continuous and respect mass conservation 
across the boundary between the tablet and the agar. At all other boundaries reflective 
boundary conditions are assumed. The initial concentration of tobramycin in the water 
fraction of the tablet is             when we assume that the tobramycin is 
quickly going into solution. The numerical solution of the diffusion equation is 
performed in COMSOL Multiphysics®. ver. 5.3.4 Comsol AB, Sweden.  
 
 
Results 
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Minimum Biofilm Eradication Concentration (MBEC) 
Fig. 1 shows that the MBEC of P. aeruginosa PAO1 to tobramycin increased with 
time from 0.5µg/ml (1 h) to 2-4µg/ml after 4-6h and 8-16µg/ml after 10-24h .  
Calculated time-dependent concentration of tobramycin in the agar plate 
Comparison between the full 3D calculation, the 3D calculation ignoring the porosity 
of the tablet, the full 2D calculation, and the approximate Gaussian solution described 
above is shown in supplemental to Fig. 2 [diffusion_models.eps]. In the 3D 
calculation, we are displaying the concentration at the agar surface since this is where 
the bacteria reside. It is seen that, particularly at early times compared to the vertical 
equilibration time and small radii, it is of importance to perform the full calculation.  
The concentration of tobramycin at radii ranging from 6.5mm to 15mm (lowest curve) 
as a function of time in the full 3D model including the effect of porosity of the 
NEOSENSITABS® is shown in Fig. 2 [diffusion_model_porous.eps]. The 
concentration at the top of the agar plate is plotted. For reference, the underlying, 
calculated, concentrations are listed in supplemental Table 3 as a function of time and 
radius. The concentration of tobramycin profile in agar 7h after placing the 
NEOSENSITAB® tablet is shown in Fig. 3. 
Growth of P. aeruginosa on blood agar plates during susceptibility testing with 
tobramycin disks. 
By counting the bacterial cells on the agar surface using stereomicroscopy and by 
blotting the growth on the surface of the blood agar with a microscopy slide, fix it 
with methanol and stain it with Methylene blue and study the results with a light 
microscope, the lag phase of P. aeruginosa after seeding the blood agar susceptibility 
medium was determined to be ≈ 2h. Thereafter the doubling time became ≈ 30min. 
during the 7h of observation. Formation of an inhibition zone around the tobramycin 
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disk was visible both with the naked eye and the stereomicroscope after 5h with an 
inoculum of 10
7
/ml (Table 1) which means that the number of cells had increased by a 
factor ≈28 (= 256). The inhibition zone was already visible after 3.5h when the 
inoculum was 10
8
/ml. 
Fig. 4 and Table 1 show the observed inhibition zone diameter and Table 2, Fig 2 and 
supplemental to Fig. 2 show the calculated results of the agar diffusion tests with 
tobramycin NEOSENSITABS® added at time 0 to +7h after the inoculation and onset 
of the incubation of the plates with P. aeruginosa PAO1 (Fig 4). As expected, it is 
seen that the later the tobramycin tablets were placed on the inoculated agar surface, 
the smaller became the inhibition zone indicating that the increasing amount of the 
visible growth could not be lysed by delayed placement of the tobramycin tablet on 
top of the growth.  
The morphology of the bacterial growth inside and outside the inhibition zone as 
visualized by stereomicroscopy is shown in Fig. 5A, B, C. The bacterial matrix is 
clearly seen at the border and outside the border of the inhibition zone.  
Subculture guided by stereomicroscopy after 24h incubation from the area inside the 
inhibition zone even up to the border of the zone and from the area where the early 
zone had been visible after 5h incubation failed to show any growth and the bacteria 
had therefore been killed by tobramycin (Fig. 5, 6, 7).  On the other hand, subculture 
from the border of the final zone always showed growth so the bacteria had survived 
tobramycin. These results were confirmed by propidium iodide staining in a few 
experiments (Live/Dead cell viability assay (ThermoFisher, USA, data not shown). 
The bacterial growth in the border of the inhibition zone had therefore obtained 
properties characteristics for biofilm growth which is observed from Fig. 7, C & E 
and thereby the growing biofilm aggregates had become more tolerant to tobramycin 
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than the seeded planktonic bacteria. The size of the dead bacterial aggregates inside 
the inhibition zones and the calculated and observed growth of the bacteria indicate, 
that when the aggregates are ≤ ≈64 cells (after 5h of incubation with a 2h lag phase, 
Fig. 8B) they are later killed inside the early inhibition zone by 3.2-6.3µg/ml 
tobramycin (Table 2, 7-24h). After 7h (the final inhibition zone), when the bacterial 
aggregates reach ≈256 cells, then they remain tolerant against the tobramycin 1.8-5.3 
µg/ml (Table 2, 7-24 h) and continue to grow in agreement with the biofilm results of 
the MBEC shown in Fig. 1.  The border of the inhibition zone was sharply marked 
and the bacterial cells – many with filamentous shape – were separated by a self-
produced matrix which is characteristic for biofilm growth (Fig. 5B, Fig. 7 C & E). 
 
Polysaccharides are present in the bacterial matrix of the P. aeruginosa aggregates 
and biofilm growth 
Fig. 8 A shows, that the matrix produced by the bacterial growth at the border and 
especially outside the border of the inhibition zone contains polysaccharide which 
become visible by the Alcian blue stain. In Fig. 8C & D it is seen, that both the 
outline or surface of the bacteria – visualised as a blue-stained ring outlining the 
bacterial cell – and the extracellular matrix contain polysaccharide. At least part of the 
of polysaccharide is identified as PSL (Fig. 8E & F). Fig. 8B shows 2 polysaccharide 
containing bacterial aggregates which were located in the inhibition zone close to its 
border and had stopped growing. Each of these aggregates contains ≈64 cells but 
stereomicroscopy guided subcultures from such regions inside the inhibition zone 
never gave growth, indicating that these small aggregates had been killed by 
tobramycin.   
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 Discussion 
Diffusion of tobramycin takes place in the water segment of the medium used for 
susceptibility testing. Generally, therefore, the results of this study are independent of 
the medium used.  Bacteria and fungi occur as individual (planktonic) cells or 
clustered together in aggregates (biofilms) which may or may not adhere to surfaces. 
Microbial biofilms are defined as structured consortia (aggregates) of microbial cells 
surrounded by a self-produced polymer matrix (17). Biofilm growing bacteria are 
much more tolerant (= reversible resistance induced by the biofilm mode of growth in 
contrast to genetic resistance caused by mutations or horizontal gene transference) to 
antibiotics than planktonic bacteria (17-19). Colonies of bacteria growing on agar 
plates are surface-adhering biofilms (20) and are therefore much more tolerant to 
antibiotics than the inoculated planktonic bacterial inoculum used for determining 
antibiotic susceptibility by the agar diffusion method. Additionally, the thicker the 
colony is, the longer is the diffusion time which scales as the square of the diffusion 
distance (21). In spite of the much higher tolerance to antibiotics of biofilms measured 
by MBEC (analogous to the planktonic Minimal Bactericidal Concentration = MBC), 
the pharmacokinetic/pharmacodynamic properties of antibiotics follow the same rules 
for planktonic and biofilm growing bacteria (13, 22, 23).  
Generally, the in vitro formation of bacterial biofilms on a surface follows five steps: 
1) reversible adhesion, 2) irreversible adhesion, 3) the bacteria divide to form 
aggregates and extracellular matrix is produced forming a young biofilm, 4) the 
biofilm maturates and becomes structured, 5) dispersal of single cells and sludging off 
of biofilm aggregates (24). Our results from the present tobramycin agar diffusion 
assay agree with the first 4 steps. Planktonic bacteria are seeded and starts to grow 
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and form aggregates and when the aggregates become > ≈64 cells after 5h of 
incubation, they are more tolerant to tobramycin and continue to grow and form a 
mature biofilm 256 cells) after 7h of incubation which is completely tolerant to 
tobramycin. These observations correlate well to previously published results (25) 
which showed in a surface-attached bacterial colony model that the bacterial cells are 
entering in the tolerant, stationary growth after 6-7h.  The correlation between the 
decreasing zone diameter and the delayed placing of the tobramycin tablet after 
seeding is in accordance with the results reported by Nichols et al. 1988 (11).  The 4 
step of biofilm formation correlates also with the gradual increasing MBEC.   
The calculations of the tobramycin concentrations in the agar explains the formation 
of the early and the stable inhibition zones, although the growth conditions are 
different on agar plates and on pegs in microtiter plates as also reported by Abbanat et 
al. 2014 (20). 
The formation of the biofilm matrix (step 3-4) was also shown to occur in our 
experiments. Generally, the biofilm matrix consists of polysaccharides, which is the 
most important component, proteins (e.g. pili, other adhesins, flagella) and eDNA 
produced by the bacteria, and in vivo also of components from the host (26, 27). We 
have now shown, that abundance of matrix polysaccharide is produced by the non-
mucoid P. aeruginosa PAO1 during the formation of aggregates and biofilm and that 
the PSL polysaccharide is produced, which has been shown to be important for 
biofilm formation in non-mucoid strains (14, 28). Other polysaccharides which are 
stained by Alcian blue are e.g LPS and also alginate (29) which is produced in small 
amounts by the non-mucoid PAO1 and is further induced when a P. aeruginosa 
PAO1 biofilm is exposed to imipenem (30). Alginate is the dominating matrix 
polysaccharide in vitro and in vivo in biofilms of mucoid phenotypes (30).  
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There is an important and clinically relevant interpretation of the role of transition 
from planktonic mode of growth to biofilm mode of growth for the formation of the 
inhibition zone. The conventional interpretation of the diameter of the inhibition zone 
is that the category Susceptible (S) based on clinical breakpoints (8) indicates that it is 
probably successful to treat and eradicate infections caused by planktonic growing 
bacteria. However, the biofilm mode of growth in the border of the inhibition zone 
and the corresponding tobramycin concentration in the agar offers the new 
interpretation, that the agar diffusion assay shows that it is probably not successful to 
treat and eradicate biofilm infections caused by the bacteria in question at least if a 
conventional dosing regime is used.  This interpretation underlines, that the 
conventional interpretation of agar diffusion – like microtiter dilution assays - does 
not provide key information to clinicians concerning treatment of biofilm infections 
(17). The agar diffusion assay in contrast to the microtiter dilution assay gives visual 
information about the increased antibiotic tolerance of the biofilm mode of growth. 
The Calgary device, which we used for determination the time-dependent  increase of 
tolerance to tobramycin, is designed for measuring the MBEC of adhering biofilms 
and may be used for that purpose in the clinical microbiology laboratory (12, 13, 17). 
 In conclusion, the inhibition zone formation during agar diffusion 
susceptibility testing is due to a switch from planktonically growing bacteria to 
biofilm growing bacteria with increased tolerance to antibiotics. The inhibition zone 
gives the clinical important information, that biofilm growing bacteria are tolerant to 
the dose of antibiotic recommended for infections caused by planktonic growing 
bacteria. Therefore, if treatment failure or recurrence occur, clinicians should suspect 
that the reason may be that biofilm growing bacteria are causing the infection.  
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Figures and legends to the figures 
 
 
 
 
 
 
Fig. 1. Minimum Biofilm Eradication Concentration (MBEC) was performed using 
the Calgary Biofilm Device (12). MBEC was determined at the specified time (h) 
after start of the biofilm growth of P. aeruginosa PAO1  (13). 
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Fig. 2. Concentration of tobramycin at radii ranging from 6.5mm to 15mm (lowest 
curve) as a function of time in the full 3D model including the effect of porosity of the 
NEOSENSITABS® tablet [diffusion_model_porous.eps]. The radius is taken from 
the centre of the tablet. The concentration at the top of the agar plate is plotted.  
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Fig. 3. Top: Illustration of the concentration of tobramycin profile in agar 7h after 
placing the NEOSENSITAB® tablet. Bottom: Cross section with indications of the 
1µg/ml and 5µg/ml contours for the full calculation (yellow) and the shifted gaussian 
(red). [DiscDiffusionPorous.eps]. 
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Fig. 4  Correlation between the diameter of the inhibition zone of P. aeruginosa 
PAO1 and the time after seeding of the agar plate (inoculum 10
7
/ml) where the 
NEOSENSITABS® tobramycin tablet was placed on surface of the agar and the 
diffusion began.  Top: time 0h, clockwise time +1h, +2h, +3h, +4h, +5h, +6h, +7h 
(center). The plates were incubated for 24h at 37
o
C.   
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Fig. 5A, B, C. Stereomicroscopy photos (A: magnification x 40, B & C: x 100) of the 
P. aeruginosa PAO1 cells in the inhibition zone around a tobramycin 
NEOSENSITABS® tablet, 24h incubation. A: The tobramycin tablet is seen at the left 
side and the border of the inhibition zone is indicated by 2 arrows. B: close up, the 
arrows are placed as in A. The surface of the growth outside the inhibition zone shows 
presence of a self-produced matrix, C: the morphology of the bacteria inside the 
inhibition zone. The scratches in the agar surface in A and C are artificial landmarks 
to facilitate the microscopy. 
 
A - 1h      B - 3h 
 
C - 4h      D - 5h 
 
E - 6h      F - 7h 
 
G - 24h 
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Fig. 6A, B, C, D, E, F, G. Growth of P. aeruginosa PAO1 (inoculum 10
7
/ml) seeded 
on the agar surface with a tobramycin NEOSENSITABS® tablet and incubated at 
37
o
C for 24h. The surface - outside the area where the inhibition zone was expected - 
was blotted with microscope slides, fixed with methanol and stained with Methylene 
blue. 1000 x magnification. From top left A, after 1h incubation; B, after 3h; C, after 
4h; D, after 5h; E, after 6h; F, after 7h; G, after 24h.  
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Fig. 7 A, B, C, D, E. Growth of P. aeruginosa PAO1 (inoculum 10
7
/ml) seeded on 
the agar surface and incubated at 37
o
C for 24h with a tobramycin NEOSENSITABS® 
tablet. The surface across the inhibition zone was blotted with microscope slides, 
fixed with methanol and stained with Methylene blue. 1000 x magnification. A & C, 
the border of the inhibition zone showing dense growth and a matrix between the 
bacterial cells. The bacterial aggregates inside the inhibition zone (also shown in B & 
D) are dead as shown by stereomicroscopic guided subculture. E shows filamentous 
bacterial cells in the border of the inhibition zone probably due to the influence of 
tobramycin and the biofilm mode of growth. The bacteria inside the border of the 
inhibition zone are viable and showed dense growth after stereomicroscopic guided 
subculture. 
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C      D 
 
E      F 
 
Fig. 8 A, B, C, D, E, F.  Growth of P. aeruginosa PAO1 (inoculum 10
7
/ml) seeded on 
the agar surface with a tobramycin NEOSENSITABS® tablet and incubated at 37
o
C 
for 24h. The surface across the inhibition zone was blotted with microscope slides, 
fixed with methanol and stained with Methylene blue. 1000 x magnification. A-D: 
polysaccharide production visualized by Alcian blue staining, black arrow= surface 
rings of polysaccharide on the bacterial cells, orange arrow = extracellular 
polysaccharide.  A: The border of the inhibition zone (arrow). B-D: The area just 
inside the border of the inhibition zone. E-F: The bacterial growth outside the 
inhibition zone, P. aeruginosa PSL polysaccharide visualized by FITC-HHA lectin 
staining; orange arrows = green fluorescence stained PSL. E-F: Confocal laser 
scanning microscopy photo.  
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Tables 
Table 1. Correlation between the diameter of the inhibition zone of P. aeruginosa 
PAO1 and the time (0h to +7h) after inoculation of the agar plate (inoculum 10
7
/ml) 
where the tobramycin tablet (NEOSENSITABS®) was placed on surface of the agar 
and the diffusion began. The zone was read every 30min.  
___________________________________________________________________________________ 
Tobramycin      Inhibition zone (mm) read after incubation for: 
placed at:    1-4h  5h 6h 7h 24h 
___________________________________________________________________________________ 
0h     invisible  22 23 24 24 <* 
+1h     ”  19 22 23 23 < 
+2h     ”  18 19 19 19 < 
+3h     ”  14 16 16 16 < 
+4h     ”  n.e.z. 14 15 15 < 
+5h     ”  n.e.z. n.e.z. 14 14 =** 
+6h     ”  n.e.z. n.e.z. n.e.z. 15  
+7h     ”  n.z.e. n.z.e. n.z.e. 15 
___________________________________________________________________________________ 
n.e.z.: no evaluable zone, *< the inhibition zone increased from barely visible to 24h, =** the 
inhibition zone was stable from barely visible to 24h. 
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Table 2. Calculated tobramycin concentration in agar at the border of the early 
(small) and the final (large) P. aeruginosa PAO1 inhibition zone after diffusion for n 
h (MIC= 0.064 µg/ml). NEOSENSITABS® containing 40µg diffusible tobramycin 
was placed on the inoculated agar (inoculum 10
7
/ml) immediately (0h) or 1h, 2h, 3h, 
4h, 5h later. Same experiment as in Table 1. 
___________________________________________________________________________________ 
  Tobramycin concentration in the border of the inhibition zone
   
   Early inhibition zone Final inhibition zone 
   after 5h incubation after 7h incubation 
___________________________________________________________________________________ 
Tobramycin Diffusion 22mm diameter  24mm diameter 
placed at time 
0h   5h  1.9 µg/ml  0.9 µg/ml  
  7h   3.2 µg/ml  1.8 µg/ml 
  24h  6.3 µg/ml  5.3 µg/ml 
    19mm diameter  23mm diameter 
+1h  4h  3.7µg/ml  0.8µg/ml 
  6h  5.9µg/ml  1.9µg/ml 
    18mm diameter  19mm diameter 
+2h  3h  3.5µg/ml  2.3µg/ml 
  5h  6.6µg/ml  4.9µg/ml 
    14mm diameter  16mm diameter 
+3h  2h  12.4µg/ml  4.7µg/ml 
  4h  18.2µg/ml  10.1µg/ml 
    -*   15mm diameter 
+4h  1h  -   - 
  3h  -   11.5µg/ml 
    -   14mm diameter 
+5h  0h  -   - 
  2h  -   12.4µg/ml 
*No zone 
 
 
